This inventor holds 1 USPTO granted patent. Top assignee: Biochemie Gesellschaft M.b.h. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Ludwig Miller: Innovator in Pharmaceutical Chemistry
Introduction
Ludwig Miller is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of purification processes for complex compounds. His work has implications for the production of important medications.
Latest Patents
Miller holds a patent for a purification process involving a crystalline compound known as 2-(aminothiazol-4-yl)-2-(tert.butoxycarbonylmethoxyimino)acetic acid-S-mercapto-benzo-thiazolylester. This patent also covers a crystalline salt of a 7-[2-(aminothiazol-4-yl)-2-(carboxymethoxyimino)acetamido]-3-vinyl-3-cephem-4-carboxylic acid. The process includes the use of these salts in the production of cefixime, particularly in the form of a trihydrate.
Career Highlights
Miller is associated with Biochemie Gesellschaft M.b.h., where he has been instrumental in advancing research and development in pharmaceutical processes. His innovative approaches have led to improved methods for synthesizing and purifying essential compounds.
Collaborations
Throughout his career, Miller has collaborated with esteemed colleagues such as Werner Veit and Hubert Sturm. These partnerships have fostered a collaborative environment that enhances the research output and innovation within the company.
Conclusion
Ludwig Miller's contributions to pharmaceutical chemistry, particularly through his patented purification processes, highlight his role as an innovator in the field. His work continues to influence the production of vital medications, showcasing the importance of innovation in healthcare.